SAN DIEGO, Oct. 29, 2019 /PRNewswire/ -- Shareholder Rights
Law Firm Johnson Fistel, LLP, is investigating potential claims
against Geron Corporation ("Geron") (NASDAQ: GERN) on behalf of
investors. Geron is a biopharmaceutical company.
Specifically, the investigation seeks to determine whether
certain statements regarding the results of a clinical drug study
of imetelstat called IMbark were false and misleading when
made. Imetelstat was intended to treat certain cancers that
occur in bone marrow and the IMbark study was designed to ascertain
whether imetelstat helped patients with a cancer called
myelofibrosis. Geron was developing imetelstat in partnership
with Janssen Biotech Inc. ("Janssen"), a division of Johnson &
Johnson. On September 27, 2018,
the company issued a press release stating that patients in the
IMbark study had shown only 10% spleen response rate and 32%
symptom response rate. The company also announced that
Janssen had terminated its partnership with the Geron for the
development of imetelstat. Following this news, the price of
Geron's stock dropped from $6.23 to
$2.31 on September 27, 2018, a decrease of over
62%.
If you lost money, realized or unrealized on your Geron
investment, and are interested in learning more about
the investigation or your legal rights and remedies, please contact
Jim Baker
(jimb@johnsonfistel.com) by email or phone at 619-814-4471.
If emailing, please include a phone number.
Additionally, you can [click here to join this
action]. There is no cost or obligation to you.
About Johnson Fistel,
LLP:
Johnson Fistel, LLP is a nationally
recognized shareholder rights law firm with offices in California, New
York, and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please visit
http://www.johnsonfistel.com. Attorney advertising. Past results do
not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com
[click here to join this action]
View original
content:http://www.prnewswire.com/news-releases/geron-gern-alert-johnson-fistel-launches-investigation-into-geron-corporation-investors-encouraged-to-contact-firm-300946852.html
SOURCE Johnson Fistel, LLP